Balaxi Pharmaceuticals consolidated net profit rises 52.03% in the March 2022 quarter

Sales rise 68.27% to Rs 89.10 crore

Net profit of Balaxi Pharmaceuticals rose 52.03% to Rs 12.71 crore in the quarter ended March 2022 as against Rs 8.36 crore during the previous quarter ended March 2021. Sales rose 68.27% to Rs 89.10 crore in the quarter ended March 2022 as against Rs 52.95 crore during the previous quarter ended March 2021.

For the full year,net profit rose 24.96% to Rs 47.66 crore in the year ended March 2022 as against Rs 38.14 crore during the previous year ended March 2021. Sales rose 20.78% to Rs 279.39 crore in the year ended March 2022 as against Rs 231.33 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales89.1052.95 68 279.39231.33 21 OPM %12.5919.47 -17.9718.33 - PBDT15.1910.03 51 55.0344.63 23 PBT15.029.97 51 54.5244.33 23 NP12.718.36 52 47.6638.14 25

Powered by Capital Market - Live News